# HCCS

## Overview
The HCCS gene encodes the enzyme holocytochrome c synthase, which is integral to the biogenesis of c-type cytochromes within the mitochondria. This enzyme is categorized as a mitochondrial enzyme and plays a pivotal role in the electron transport chain by facilitating the covalent attachment of heme to apocytochrome c, forming holocytochrome c. This process is essential for the stability and function of cytochrome c, a key component in cellular respiration and apoptosis. The HCCS gene is highly conserved across species, underscoring its fundamental role in cellular energy metabolism. Mutations in HCCS can lead to mitochondrial dysfunction and are implicated in disorders such as microphthalmia with linear skin defects syndrome (MLS), highlighting its clinical significance (Babbitt2015Mitochondrial; Babbitt2014Conserved).

## Structure
The human holocytochrome c synthase (HCCS) is a mitochondrial enzyme involved in the biogenesis of c-type cytochromes. The primary structure of HCCS includes several conserved amino acid residues that are crucial for its function. These residues are organized into four putative domains, with Domains I and II being involved in heme binding. Domain I includes residues such as Trp118, Pro121, and Asn128, while Domain II contains His154 and Asn155. His154 is a critical axial ligand for heme binding (Babbitt2014Conserved).

The secondary structure of HCCS features an alpha helix adjacent to the CXXCH motif, which is necessary for the recognition and maturation of cytochrome c (Sutherland2021In). The tertiary structure of HCCS is characterized by a surface at the active site that is acidic, potentially interacting with the basic features of the alpha helix 1 (Sutherland2021In).

HCCS does not appear to form a quaternary structure through interactions with other proteins, as the context does not provide information on this aspect. There is no mention of post-translational modifications or splice variant isoforms in the provided context.

## Function
The human gene HCCS (holocytochrome c synthase) is crucial for the biogenesis of cytochrome c, a key component of the mitochondrial electron transport chain. HCCS catalyzes the covalent attachment of a heme cofactor to apocytochrome c, a process essential for the stability and function of cytochrome c. This attachment occurs in the mitochondrial intermembrane space and involves the formation of thioether bonds between the heme and cysteine residues in the CXXCH motif of cytochrome c (Babbitt2015Mitochondrial; Babbitt2014Conserved).

HCCS operates through a four-step mechanism: binding of heme, binding of apocytochrome c, formation of thioether bonds, and release of holocytochrome c. This process is critical for the proper folding and stability of cytochrome c, enabling it to participate in electron transport and ATP production (Babbitt2015Mitochondrial; Mendez2017Engineered). The enzyme's activity is also linked to programmed cell death, as cytochrome c release from mitochondria can trigger apoptosis (Babbitt2015Mitochondrial).

Mutations in HCCS can lead to mitochondrial pathologies, highlighting its importance in maintaining cellular respiration and energy metabolism (Babbitt2015Mitochondrial; Babbitt2014Conserved).

## Clinical Significance
Mutations in the HCCS gene are associated with microphthalmia with linear skin defects syndrome (MLS), a rare genetic disorder characterized by eye abnormalities and distinctive skin defects. This condition is primarily observed in females and is often lethal in males. The eye abnormalities can include microphthalmia, where one or both eyes are abnormally small, and anophthalmia, the absence of one or both eyes. The skin defects typically present as linear lesions that follow the lines of Blaschko, which are patterns of skin development.

Alterations in the expression or function of HCCS can disrupt mitochondrial processes, as the gene plays a crucial role in mitochondrial function. Such disruptions can contribute to a range of mitochondrial diseases, given the gene's involvement in the synthesis of holocytochrome c, a component essential for the electron transport chain and cellular energy production. The precise mechanisms by which HCCS mutations lead to the clinical manifestations of MLS and other mitochondrial disorders are still under investigation, but they underscore the gene's critical role in maintaining mitochondrial integrity and function.

## Interactions
The human gene HCCS (holocytochrome c synthase) is primarily involved in the biogenesis of c-type cytochromes, facilitating the covalent attachment of heme to cytochrome c. This interaction is crucial for mitochondrial respiration and programmed cell death. HCCS interacts with apocytochrome c in a four-step process: it first binds to the heme cofactor, then recognizes and binds to apocytochrome c, catalyzes the formation of covalent thioether bonds between cytochrome c and heme, and finally releases holocytochrome c to fold into its native conformation (Babbitt2014Conserved).

The interaction between HCCS and cytochrome c involves specific residues, such as His154, which acts as an axial ligand to the heme iron, and His19 of apocytochrome c, which forms the second axial ligand at the HCCS active site (Sutherland2021In). Mutations in conserved residues, such as E159K and R217C, can affect heme binding and protein folding, impacting the function of HCCS (Babbitt2014Conserved). The study of HCCS mutants has shown that certain mutations can enhance or inhibit the release of holocytochrome c, indicating the importance of these interactions in the enzyme's function (Babbitt2014Conserved).


## References


[1. (Babbitt2015Mitochondrial) Shalon E. Babbitt, Molly C. Sutherland, Brian San Francisco, Deanna L. Mendez, and Robert G. Kranz. Mitochondrial cytochrome c biogenesis: no longer an enigma. Trends in Biochemical Sciences, 40(8):446–455, August 2015. URL: http://dx.doi.org/10.1016/j.tibs.2015.05.006, doi:10.1016/j.tibs.2015.05.006. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tibs.2015.05.006)

[2. (Sutherland2021In) Molly C Sutherland, Deanna L Mendez, Shalon E Babbitt, Dustin E Tillman, Olga Melnikov, Nathan L Tran, Noah T Prizant, Andrea L Collier, and Robert G Kranz. In vitro reconstitution reveals major differences between human and bacterial cytochrome c synthases. eLife, May 2021. URL: http://dx.doi.org/10.7554/elife.64891, doi:10.7554/elife.64891. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.64891)

[3. (Babbitt2014Conserved) Shalon E. Babbitt, Brian San Francisco, Eric C. Bretsnyder, and Robert G. Kranz. Conserved residues of the human mitochondrial holocytochrome c synthase mediate interactions with heme. Biochemistry, 53(32):5261–5271, August 2014. URL: http://dx.doi.org/10.1021/bi500704p, doi:10.1021/bi500704p. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi500704p)

[4. (Mendez2017Engineered) Deanna L. Mendez, Shalon E. Babbitt, Jeremy D. King, John D’Alessandro, Michael B. Watson, Robert E. Blankenship, Liviu M. Mirica, and Robert G. Kranz. Engineered holocytochrome c synthases that biosynthesize new cytochromes c. Proceedings of the National Academy of Sciences, 114(9):2235–2240, February 2017. URL: http://dx.doi.org/10.1073/pnas.1615929114, doi:10.1073/pnas.1615929114. This article has 16 citations.](https://doi.org/10.1073/pnas.1615929114)